These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12668890)

  • 21. Ischemia/reperfusion injury: effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition.
    Duehrkop C; Rieben R
    Biochem Pharmacol; 2014 Mar; 88(1):12-22. PubMed ID: 24384116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes.
    Leslie RG; Nielsen CH
    Immunology; 2004 Jan; 111(1):86-90. PubMed ID: 14678202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement and biocompatibility.
    Mollnes TE
    Vox Sang; 1998; 74 Suppl 2():303-7. PubMed ID: 9704460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated.
    Sølvik UØ; Haraldsen G; Fiane AE; Boretti E; Lambris JD; Fung M; Thorsby E; Mollnes TE
    Transplantation; 2001 Dec; 72(12):1967-73. PubMed ID: 11773897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic inhibition of the complement system. Y2K update.
    Asghar SS; Pasch MC
    Front Biosci; 2000 Sep; 5():E63-81. PubMed ID: 10966868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The complement system and its biological activities].
    Colomb MG; Arlaud GJ
    C R Seances Soc Biol Fil; 1980; 174(4):615-26. PubMed ID: 6449243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlling the complement system for prevention of red cell destruction.
    Yazdanbakhsh K
    Curr Opin Hematol; 2005 Mar; 12(2):117-22. PubMed ID: 15725901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement therapeutics; history and current progress.
    Morgan BP; Harris CL
    Mol Immunol; 2003 Sep; 40(2-4):159-70. PubMed ID: 12914822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of complement activation in the isolated heart. Role of the terminal complement components.
    Homeister JW; Satoh P; Lucchesi BR
    Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Into the third century of complement research.
    Morgan BP; Daha M; Meri S; Nicholson-Weller A
    Immunol Today; 2000 Dec; 21(12):603-5. PubMed ID: 11188795
    [No Abstract]   [Full Text] [Related]  

  • 31. A computational model for the evaluation of complement system regulation under homeostasis, disease, and drug intervention.
    Zewde N; Morikis D
    PLoS One; 2018; 13(6):e0198644. PubMed ID: 29874282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the complement system in diabetic nephropathy.
    Flyvbjerg A
    Nat Rev Nephrol; 2017 May; 13(5):311-318. PubMed ID: 28262777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clionasterol: a potent inhibitor of complement component C1.
    Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
    Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.
    Ivanovska N; Yossifova T; Vassileva E; Kostova I
    Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):557-62. PubMed ID: 7760580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement and autoimmune glomerular diseases.
    Quigg RJ
    Curr Dir Autoimmun; 2004; 7():165-80. PubMed ID: 14719380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement proteins and complement inhibitors in Alzheimer's disease.
    McGeer PL; McGeer EG
    Res Immunol; 1992; 143(6):621-4. PubMed ID: 1455053
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of complement and perspectives for intervention in transplantation.
    Chen G; Chen S; Chen X
    Immunobiology; 2013 May; 218(5):817-27. PubMed ID: 23182708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement in atherosclerosis: friend or foe?
    Speidl WS; Kastl SP; Huber K; Wojta J
    J Thromb Haemost; 2011 Mar; 9(3):428-40. PubMed ID: 21155967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement and complement regulatory proteins as potential molecular targets for vascular diseases.
    Acosta J; Qin X; Halperin J
    Curr Pharm Des; 2004; 10(2):203-11. PubMed ID: 14754399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.